top of page

Breast Cancer: Worth its Price at DNAldi

An American provider is shaking up the market with its genetic tests. For the unbeatable price of 249 US dollars it is able to offer its patients a search for 19 recognised cancer mutations, advice inclusive. A critical look behind the scenes.


Click on this link for more information.

source: http://news.doccheck.com/en/4474/breast-cancer-worth-its-price-at-dnaldi/

#Pharmanews

Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page